Inventor · disambiguated record
Andrew W. Hinman
Also filed as: HINMAN ANDREW W
22 granted patents·13 pending applications·232 citations·filing 2009–2023
95Inventor score
Files withPTC THERAPEUTICS INC10EDISON PHARMACEUTICALS INC8BIOELECTRON TECH CORP6HINMAN ANDREW W6JANKOWSKI ORION D2
Top patents by PatentIndex Score
35 records- 0197US8575369B2Process for the production of alpha-tocotrienol and derivativesWESSON KIERON E·Filed 2012·Granted Nov 5, 2013·34 cites·28 claims
- 0297US8106223B2Process for the production of alpha-tocotrienol and derivativesWESSON KIERON E·Filed 2009·Granted Jan 31, 2012·46 cites·28 claims
- 0395US8716527B22-substituted-p-quinone derivatives for treatment of oxidative stress diseasesHINMAN ANDREW W·Filed 2009·Granted May 6, 2014·35 cites·14 claims
- 0494US8716486B22-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseasesHINMAN ANDREW W·Filed 2009·Granted May 6, 2014·37 cites·31 claims
- 0592US11174212B22,3,5-trimelthyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disordersPTC THERAPEUTICS INC·Filed 2021·Granted Nov 16, 2021·5 cites·32 claims
- 0691US10703701B2Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disordersPTC THERAPEUTICS INC·Filed 2016·Granted Jul 7, 2020·7 cites·23 claims
- 0790US8952071B2(Het)aryl-p-quinone derivatives for treatment of mitochondrial diseasesHINMAN ANDREW W·Filed 2009·Granted Feb 10, 2015·18 cites·16 claims
- 0889US10981855B2Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disordersPTC THERAPEUTICS INC·Filed 2020·Granted Apr 20, 2021·2 cites·18 claims
- 0988US11667596B22,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disordersPTC THERAPEUTICS INC·Filed 2021·Granted Jun 6, 2023·1 cites·19 claims
- 1087US10071978B2Process for the production of alpha-tocotrienol and derivativesBIOELECTRON TECH CORP·Filed 2016·Granted Sep 11, 2018·3 cites·16 claims
- 1186US9296712B2Resorufin derivatives for treatment of oxidative stress disordersEDISON PHARMACEUTICALS INC·Filed 2013·Granted Mar 29, 2016·12 cites·19 claims
- 1285US10470986B2Resorcinol compounds for dermatological useCONOPCO INC·Filed 2014·Granted Nov 12, 2019·10 cites·5 claims
- 1385US9486435B2(Het)aryl-p-quinone derivatives for treatment of mitochondrial diseasesEDISON PHARMACEUTICALS INC·Filed 2014·Granted Nov 8, 2016·7 cites·17 claims
- 1483US9090576B22-substituted-p-quinone derivatives for treatment of oxidative stress diseasesEDISON PHARMACEUTICALS INC·Filed 2014·Granted Jul 28, 2015·3 cites·22 claims
- 1583US2022204469A1Process for the production of alpha-tocotrienol and derivativesPTC THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1682US9629815B2Benzoquinone derivatives for treating oxidative stress disordersEDISON PHARMACEUTICALS INC·Filed 2013·Granted Apr 25, 2017·5 cites·17 claims
- 1781US9073873B22-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseasesEDISON PHARMACEUTICALS INC·Filed 2014·Granted Jul 7, 2015·4 cites·17 claims
- 1876US11312697B2Process for the production of alpha-tocotrienol and derivativesPTC THERAPEUTICS INC·Filed 2018·Granted Apr 26, 2022·0 cites·22 claims
- 1975US10189830B2Alkyl-heteroaryl substituted quinone derivatives for treatment of oxidative stress disordersBIOELECTRON TECH CORP·Filed 2014·Granted Jan 29, 2019·3 cites·14 claims
- 2075US2023339835A12,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disordersPTC THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2174US11746077B22,3,5-trimethyl-6-nonylcyclohexa-2,5-diene-1,4-dione for suppressing and treating alpha-synucleinopathies, tauopathies, and other disordersPTC THERAPEUTICS INC·Filed 2022·Granted Sep 5, 2023·0 cites·29 claims
- 2274US11680034B2Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disordersPTC THERAPEUTICS INC·Filed 2021·Granted Jun 20, 2023·0 cites·18 claims
- 2367US2014221674A1Process for the production of alpha-tocotrienol and derivativesEDISON PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2464US2010029784A1Naphthoquinone compositions with anti-aging, anti-inflammatory and skin even-toning propertiesHINMAN ANDREW W·Filed 2009·Application pending·0 cites
- 2563US2010010100A1Dermatological compositions with anti-aging and skin even-toning propertiesHINMAN ANDREW W·Filed 2009·Application pending·0 cites
- 2660US2022257533A1Methods and compositions for treatment of inflammation and oxidative stressPTC THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2754US2020121618A1Methods and compositions for treatment of inflammation and oxidative stressBIOELECTRON TECH CORP·Filed 2018·Application pending·0 cites
- 2849US9868711B2Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disordersBIOELECTRON TECH CORP·Filed 2014·Granted Jan 16, 2018·0 cites·22 claims
- 2949US9670170B2Resorufin derivatives for treatment of oxidative stress disordersBIOELECTRON TECH CORP·Filed 2014·Granted Jun 6, 2017·0 cites·20 claims
- 3047US2017209393A1Benzoquinone derivatives for treating oxidative stress disordersBIOELECTRON TECH CORP·Filed 2017·Application pending·0 cites
- 3145US2016115141A1Carboxylic acid derivatives for treatment of oxidative stress disordersEDISON PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 3242US2019241497A1Methods for analyzing p-hydroquinone levels and ratiosHINMAN ANDREW W·Filed 2017·Application pending·0 cites
- 3341US2014275045A1Phenazine-3-one and phenothiazine-3-one derivatives for treatment of oxidative stress disordersEDISON PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3438US2014031432A1Treatment of mitochondrial diseases with vitamin kJANKOWSKI ORION D·Filed 2011·Application pending·0 cites
- 3538US2013345312A1Treatment of mitochondrial diseases with naphthoquinonesJANKOWSKI ORION D·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →